Ready For RSV

Brief Educational Webinar:
Updated RSV Vaccine
Recommendations for Older Adults
& Implementation Considerations

WEBINAR INFO

Brief Educational Webinar: Updated RSV Vaccine Recommendations for Older Adults & Implementation Considerations

New routine recommendation for adults aged 75 and older and risk-based recommendation for adults aged 60-74
Clinical Considerations for RSV Vaccines in Older Adults
Pfizer RSV Vaccine Presentation Options – ‘Vial and Prefilled Syringe’ and new ‘Act-O-Vial’

Intended Audience: US healthcare professionals including but not limited to physicians, nurse practitioners, pharmacists, and physician assistants.

Continuing medical education credit is NOT associated with this event.

For more information, please visit Full Prescribing Information